Choice of calcineurin inhibitor and development of new malignancies in liver transplant recipients

被引：0
|
作者：
Blum, Eric B. [1 ]
Post, Anthony B. [1 ]
机构：
[1] Univ Hosp Cleveland, Cleveland, OH 44106 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2006年 / 101卷 / 09期
关键词：
D O I：
10.14309/00000434-200609001-00319
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
319
引用
收藏
页码：S150 / S150
页数：1
相关论文
共 50 条
  • [41] Everolimus and reduced calcineurin inhibitor therapy in pediatric liver transplant recipients: Results from a multicenter, prospective study
    Ganschow, Rainer
    Ericzon, Bo-Goran
    Dhawan, Anil
    Sharif, Khalid
    Martzloff, El-Djouher
    Rauer, Barbara
    Ng, Jennifer
    Lopez, Patricia
    PEDIATRIC TRANSPLANTATION, 2017, 21 (07)
  • [42] A novel approach to managing variation: Outpatient therapeutic monitoring of calcineurin inhibitor blood levels in liver transplant recipients
    Bucuvalas, JC
    Ryckman, FC
    Arya, G
    Andrew, B
    Lesko, A
    Cole, CR
    James, B
    Kotagal, U
    JOURNAL OF PEDIATRICS, 2005, 146 (06): : 744 - 750
  • [43] Delayed Calcineurin Inhibitor Introduction and Long Term Renal Outcomes in Liver Transplant Recipients Receiving Basiliximab Induction
    Lange, N.
    Salerno, D.
    Sammons, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 777 - 778
  • [44] Therapeutic effect of exogenously supplied lipids on calcineurin inhibitor-associated neurotoxicity in liver transplant recipients.
    Ide, K
    Ohdan, H
    ToKita, D
    Onoe, T
    Ishiyama, K
    Mitsuta, H
    Shishida, M
    Asahara, T
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 572 - 573
  • [45] Improvement in renal dysfunction after tapering calcineurin inhibitor and the introduction of mycophenolate mofetil in liver transplant recipients.
    Dale, CH
    Alghamdi, MJ
    Marotta, PJ
    LIVER TRANSPLANTATION, 2006, 12 (05) : C44 - C44
  • [46] Relationship between renal resistance index and renal function in liver transplant recipients after cessation of calcineurin inhibitor
    Eisenberger, Ute
    Sollinger, Daniel
    Stickel, Felix
    Burckhardt, Beat
    Frey, Felix J.
    CLINICAL TRANSPLANTATION, 2009, 23 (04) : 499 - 504
  • [47] Calcineurin inhibitor-free immunosuppressive protocol with basiliximab induction and everolimus in de novo liver transplant recipients
    Masetti, Michele
    Montalti, Roberto
    Rompianesi, Gianluca
    Romano, Antonio
    Guerrini, Gianpiero
    De Ruvo, Nicola
    Gerunda, Giorgio E.
    TRANSPLANT INTERNATIONAL, 2007, 20 : 124 - 125
  • [48] Differing Effects of Rapamycin or Calcineurin Inhibitor on T-Regulatory Cells in Pediatric Liver and Kidney Transplant Recipients
    Akimova, T.
    Kamath, B. M.
    Goebel, J. W.
    Meyers, K. E. C.
    Rand, E. B.
    Hawkins, A.
    Levine, M. H.
    Bucuvalas, J. C.
    Hancock, W. W.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (12) : 3449 - 3461
  • [49] Evidence for the Immunosuppressive Potential of Calcineurin Inhibitor-Sparing Regimens in Liver Transplant Recipients with Impaired Renal Function
    Tanimine, N.
    Ide, K.
    Tanaka, Y.
    Ishiyama, K.
    Onoe, T.
    Tashiro, H.
    Ohdan, H.
    TRANSPLANTATION, 2012, 94 (10) : 679 - 679
  • [50] Conversion from a Calcineurin Inhibitor to Everolimus Therapy in Maintenance Liver Transplant Recipients: A Prospective, Randomized, Multicenter Trial
    De Simone, Paolo
    Metselaar, Herold J.
    Fischer, Lutz
    Dumortier, Jerome
    Boudjema, Karim
    Hardwigsen, Jean
    Rostaing, Lionel
    De Carlis, Luciano
    Saliba, Faouzi
    Nevens, Frederik
    LIVER TRANSPLANTATION, 2009, 15 (10) : 1262 - 1269
12345